Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Intestinal organoids model human responses to infection by commensal and Shiga toxin producing Escherichia coli.

Karve SS, Pradhan S, Ward DV, Weiss AA.

PLoS One. 2017 Jun 14;12(6):e0178966. doi: 10.1371/journal.pone.0178966. eCollection 2017.

2.

Plasmonics-Based Detection of Virus Using Sialic Acid Functionalized Gold Nanoparticles.

Lee C, Wang P, Gaston MA, Weiss AA, Zhang P.

Methods Mol Biol. 2017;1571:109-116. doi: 10.1007/978-1-4939-6848-0_7.

PMID:
28281252
3.

Development of a point-of-care diagnostic for influenza detection with antiviral treatment effectiveness indication.

Murdock RC, Gallegos KM, Hagen JA, Kelley-Loughnane N, Weiss AA, Papautsky I.

Lab Chip. 2017 Jan 17;17(2):332-340. doi: 10.1039/c6lc01074a.

4.

Shiga Toxin Mediated Neurologic Changes in Murine Model of Disease.

Pradhan S, Pellino C, MacMaster K, Coyle D, Weiss AA.

Front Cell Infect Microbiol. 2016 Sep 29;6:114. eCollection 2016.

5.

AB5 Preassembly Is Not Required for Shiga Toxin Activity.

Pellino CA, Karve SS, Pradhan S, Weiss AA.

J Bacteriol. 2016 May 13;198(11):1621-1630. doi: 10.1128/JB.00918-15. Print 2016 Jun 1.

6.

Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB) Affect Protein Function.

Millen SH, Watanabe M, Komatsu E, Yamaguchi F, Nagasawa Y, Suzuki E, Monaco H, Weiss AA.

PLoS One. 2015 Sep 16;10(9):e0137379. doi: 10.1371/journal.pone.0137379. eCollection 2015.

7.

Gastrointestinal Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy Specimens: Adequate Diagnostic Yield and Accuracy Can Be Achieved without On-Site Evaluation.

O'Connor K, Cheriyan DG, Li-Chang HH, Kalloger SE, Garrett J, Byrne MF, Weiss AA, Donnellan F, Schaeffer DF.

Acta Cytol. 2015;59(4):305-10. doi: 10.1159/000439398. Epub 2015 Sep 5.

PMID:
26339900
8.

Glycolipid binding preferences of Shiga toxin variants.

Karve SS, Weiss AA.

PLoS One. 2014 Jul 1;9(7):e101173. doi: 10.1371/journal.pone.0101173. eCollection 2014.

9.

The effect of doxorubicin loading on response and toxicity with drug-eluting embolization in resectable hepatoma: a dose escalation study.

Klass D, Owen D, Buczkowski A, Chung SW, Scudamore CH, Weiss AA, Yoshida EM, Ford JA, Ho S, Liu DM.

Anticancer Res. 2014 Jul;34(7):3597-606.

PMID:
24982375
10.

Response to endoscopic therapy for biliary anastomotic strictures in deceased versus living donor liver transplantation.

Chan CH, Donnellan F, Byrne MF, Coss A, Haque M, Wiesenger H, Scudamore CH, Steinbrecher UP, Weiss AA, Yoshida EM.

Hepatobiliary Pancreat Dis Int. 2013 Oct;12(5):488-93.

PMID:
24103278
11.

Pertussis toxin B-pentamer mediates intercellular transfer of membrane proteins and lipids.

Millen SH, Schneider OD, Miller WE, Monaco JJ, Weiss AA.

PLoS One. 2013 Sep 3;8(9):e72885. doi: 10.1371/journal.pone.0072885. eCollection 2013.

12.

Failure of manganese to protect from Shiga toxin.

Gaston MA, Pellino CA, Weiss AA.

PLoS One. 2013 Jul 16;8(7):e69823. doi: 10.1371/journal.pone.0069823. Print 2013.

14.

Binding of Pk-trisaccharide analogs of globotriaosylceramide to Shiga toxin variants.

Yosief HO, Iyer SS, Weiss AA.

Infect Immun. 2013 Aug;81(8):2753-60. doi: 10.1128/IAI.00274-13. Epub 2013 May 20.

15.

Capture of uropathogenic E. coli by using synthetic glycan ligands specific for the pap-pilus.

Yosief HO, Weiss AA, Iyer SS.

Chembiochem. 2013 Jan 21;14(2):251-9. doi: 10.1002/cbic.201200582. Epub 2013 Jan 10.

16.

Colorimetric viral detection based on sialic acid stabilized gold nanoparticles.

Lee C, Gaston MA, Weiss AA, Zhang P.

Biosens Bioelectron. 2013 Apr 15;42:236-41. doi: 10.1016/j.bios.2012.10.067. Epub 2012 Nov 6.

17.

Mechanistic insight into pertussis toxin and lectin signaling using T cells engineered to express a CD8α/CD3ζ chimeric receptor.

Schneider OD, Millen SH, Weiss AA, Miller WE.

Biochemistry. 2012 May 22;51(20):4126-37. doi: 10.1021/bi3002693. Epub 2012 May 10.

18.

Shiga toxin binding to glycolipids and glycans.

Gallegos KM, Conrady DG, Karve SS, Gunasekera TS, Herr AB, Weiss AA.

PLoS One. 2012;7(2):e30368. doi: 10.1371/journal.pone.0030368. Epub 2012 Feb 13.

19.

Patient time costs and out-of-pocket costs in hepatitis C.

Federico CA, Hsu PC, Krajden M, Yoshida EM, Bremner KE, Weiss AA, Anderson FH, Krahn MD.

Liver Int. 2012 May;32(5):815-25. doi: 10.1111/j.1478-3231.2011.02722.x. Epub 2012 Jan 3.

PMID:
22221745
20.

Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection.

Hsu PC, Federico CA, Krajden M, Yoshida EM, Bremner KE, Anderson FH, Weiss AA, Krahn MD.

J Gastroenterol Hepatol. 2012 Jan;27(1):149-57. doi: 10.1111/j.1440-1746.2011.06813.x.

PMID:
21679248
21.

Reaming as an adjuvant to irrigation on bacterial presence and propagation: an open, cadaveric intramedullary fracture model.

Archdeacon MT, Kazemi N, Romanowski JR, Mobberley-Schuman PS, Weiss AA.

J Orthop Trauma. 2011 Jun;25(6):325-30. doi: 10.1097/BOT.0b013e3182009ce5.

PMID:
21577065
22.

Molecular basis of differential B-pentamer stability of Shiga toxins 1 and 2.

Conrady DG, Flagler MJ, Friedmann DR, Vander Wielen BD, Kovall RA, Weiss AA, Herr AB.

PLoS One. 2010 Dec 28;5(12):e15153. doi: 10.1371/journal.pone.0015153.

23.

Shiga toxin subtypes display dramatic differences in potency.

Fuller CA, Pellino CA, Flagler MJ, Strasser JE, Weiss AA.

Infect Immun. 2011 Mar;79(3):1329-37. doi: 10.1128/IAI.01182-10. Epub 2011 Jan 3.

24.

Detection of carbohydrate binding proteins using magnetic relaxation switches.

Kulkarni AA, Weiss AA, Iyer SS.

Anal Chem. 2010 Sep 1;82(17):7430-5. doi: 10.1021/ac101579m.

PMID:
20684523
25.

Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2.

Kulkarni AA, Fuller C, Korman H, Weiss AA, Iyer SS.

Bioconjug Chem. 2010 Aug 18;21(8):1486-93. doi: 10.1021/bc100095w.

26.

Different classes of antibiotics differentially influence shiga toxin production.

McGannon CM, Fuller CA, Weiss AA.

Antimicrob Agents Chemother. 2010 Sep;54(9):3790-8. doi: 10.1128/AAC.01783-09. Epub 2010 Jun 28.

27.

Identification and characterization of the carbohydrate ligands recognized by pertussis toxin via a glycan microarray and surface plasmon resonance.

Millen SH, Lewallen DM, Herr AB, Iyer SS, Weiss AA.

Biochemistry. 2010 Jul 20;49(28):5954-67. doi: 10.1021/bi100474z.

28.

Relapse of multiple myeloma presenting with biliary obstruction.

Coss A, Zhou C, Byrne MF, Weiss AA.

Can J Gastroenterol. 2010 Apr;24(4):237-8.

29.

Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model.

Komatsu E, Yamaguchi F, Abe A, Weiss AA, Watanabe M.

Clin Vaccine Immunol. 2010 May;17(5):807-12. doi: 10.1128/CVI.00449-09. Epub 2010 Mar 31.

30.

Glycan-based high-affinity ligands for toxins and pathogen receptors.

Kulkarni AA, Weiss AA, Iyer SS.

Med Res Rev. 2010 Mar;30(2):327-93. doi: 10.1002/med.20196. Review.

PMID:
20135686
31.

Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2.

Flagler MJ, Mahajan SS, Kulkarni AA, Iyer SS, Weiss AA.

Biochemistry. 2010 Mar 2;49(8):1649-57. doi: 10.1021/bi902084y.

32.

A rare case of isolated duodenal metastases from hepatocellular carcinoma associated with p53 and ki-67 expression: a case report.

Chung C, Al Ali J, Owen DA, Weiss AA, Yoshida EM, Tai IT.

Cases J. 2009 Dec 17;2:9344. doi: 10.1186/1757-1626-2-9344.

33.
34.

Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4.

Schneider OD, Weiss AA, Miller WE.

J Immunol. 2009 May 1;182(9):5730-9. doi: 10.4049/jimmunol.0803114.

35.

A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms.

Conrady DG, Brescia CC, Horii K, Weiss AA, Hassett DJ, Herr AB.

Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19456-61. doi: 10.1073/pnas.0807717105. Epub 2008 Dec 1.

36.

Biotinylated bi- and tetra-antennary glycoconjugates for Escherichia coli detection.

Hatch DM, Weiss AA, Kale RR, Iyer SS.

Chembiochem. 2008 Oct 13;9(15):2433-42. doi: 10.1002/cbic.200800188.

PMID:
18803208
37.

Toxicity of anthrax toxin is influenced by receptor expression.

Taft SC, Weiss AA.

Clin Vaccine Immunol. 2008 Sep;15(9):1330-6. doi: 10.1128/CVI.00103-08. Epub 2008 Jul 2.

38.

Contemporary trends in management of the upper limb in tetraplegia: a multinational perspective.

Weiss AA.

Hand Clin. 2008 May;24(2):157-60, v. doi: 10.1016/j.hcl.2008.01.004. Review.

PMID:
18456121
39.

Contemporary issues related to management of the upper limb in tetraplegia. Preface.

Mulcahey MJ, Weiss AA.

Hand Clin. 2008 May;24(2):xi. doi: 10.1016/j.hcl.2008.02.002. No abstract available.

PMID:
18456120
40.

Chronic pancreatitis: a sequela of acute fatty liver of pregnancy.

Apiratpracha W, Yoshida EM, Scudamore CH, Weiss AA, Byrne MF.

Hepatobiliary Pancreat Dis Int. 2008 Feb;7(1):101-4. Erratum in: Hepatobiliary Pancreat Dis Int. 2008 Apr;7(2):220. Charles, Scudamore H [corrected to Scudamore, Charles H].

PMID:
18234648
41.

Differentiation between structurally homologous Shiga 1 and Shiga 2 toxins by using synthetic glycoconjugates.

Kale RR, McGannon CM, Fuller-Schaefer C, Hatch DM, Flagler MJ, Gamage SD, Weiss AA, Iyer SS.

Angew Chem Int Ed Engl. 2008;47(7):1265-8. doi: 10.1002/anie.200703680. No abstract available.

PMID:
18172842
42.
43.
44.

Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis.

Flagler MJ, Strasser JE, Chalk CL, Weiss AA.

Infect Immun. 2007 Feb;75(2):760-5. Epub 2006 Nov 13.

45.

Photodynamic therapy in Barrett's esophagus: results of treatment of 17 patients.

Weiss AA, Wiesinger HA, Owen D.

Can J Gastroenterol. 2006 Apr;20(4):261-4.

46.

Characterization of serological responses to pertussis.

Watanabe M, Connelly B, Weiss AA.

Clin Vaccine Immunol. 2006 Mar;13(3):341-8.

47.

Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine.

Gamage SD, Patton AK, Strasser JE, Chalk CL, Weiss AA.

Infect Immun. 2006 Mar;74(3):1977-83.

48.

Neutralizing antibodies and persistence of immunity following anthrax vaccination.

Hanson JF, Taft SC, Weiss AA.

Clin Vaccine Immunol. 2006 Feb;13(2):208-13.

49.
50.

Acellular pertussis vaccines and complement killing of Bordetella pertussis.

Weiss AA, Patton AK, Millen SH, Chang SJ, Ward JI, Bernstein DI.

Infect Immun. 2004 Dec;72(12):7346-51.

Supplemental Content

Loading ...
Support Center